OBJECTIVE: Non-obese diabetic (NOD) mice develop an autoimmune exocrinopathy that shows similarities with Sjögren's syndrome. They provide an experimental model to study the pathoetiogenesis of this disease. MATERIALS AND METHODS: Salivary gland (SG) function and salivary sodium content were measured in 8-, 12-, 16- and 20-week-old NOD and age-matched CB6 mice. In NOD mice, SG expression of phenotypic cell markers, B cell-stimulating and costimulatory molecules were evaluated. Cytokine levels were measured in serum and SG homogenates. RESULTS: Microscopically evident SG inflammation in NOD mice was preceded by expression of intercellular adhesion molecule 1 on epithelial cells in the presence of macrophages and relatively high levels of cytokines. Next, an influx consisting of mainly T, B, natural killer, plasma and dendritic cells was seen. Most cytokines, except for interleukin (IL)12/IL23p40 and B cell-activating factor, decreased or remained stable over time, while glandular function deteriorated from 16 weeks of age onward compared with CB6 mice. CONCLUSION: Sjögren's syndrome-like disease in NOD mice occurs in multiple stages; immunological and physiological abnormalities can be detected before focal inflammation appears and salivary output declines. Extrapolating this knowledge to human subjects could help in understanding the pathogenesis and aid the identification of potential therapeutic targets.
OBJECTIVE:Non-obese diabetic (NOD) mice develop an autoimmune exocrinopathy that shows similarities with Sjögren's syndrome. They provide an experimental model to study the pathoetiogenesis of this disease. MATERIALS AND METHODS: Salivary gland (SG) function and salivary sodium content were measured in 8-, 12-, 16- and 20-week-old NOD and age-matched CB6mice. In NOD mice, SG expression of phenotypic cell markers, B cell-stimulating and costimulatory molecules were evaluated. Cytokine levels were measured in serum and SG homogenates. RESULTS: Microscopically evident SG inflammation in NOD mice was preceded by expression of intercellular adhesion molecule 1 on epithelial cells in the presence of macrophages and relatively high levels of cytokines. Next, an influx consisting of mainly T, B, natural killer, plasma and dendritic cells was seen. Most cytokines, except for interleukin (IL)12/IL23p40 and B cell-activating factor, decreased or remained stable over time, while glandular function deteriorated from 16 weeks of age onward compared with CB6mice. CONCLUSION: Sjögren's syndrome-like disease in NOD mice occurs in multiple stages; immunological and physiological abnormalities can be detected before focal inflammation appears and salivary output declines. Extrapolating this knowledge to human subjects could help in understanding the pathogenesis and aid the identification of potential therapeutic targets.
Authors: S Cha; S C van Blockland; M A Versnel; F Homo-Delarche; H Nagashima; J Brayer; A B Peck; M G Humphreys-Beher Journal: Exp Clin Immunogenet Date: 2001
Authors: C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman Journal: Ann Rheum Dis Date: 2002-06 Impact factor: 19.103
Authors: J A Gross; J Johnston; S Mudri; R Enselman; S R Dillon; K Madden; W Xu; J Parrish-Novak; D Foster; C Lofton-Day; M Moore; A Littau; A Grossman; H Haugen; K Foley; H Blumberg; K Harrison; W Kindsvogel; C H Clegg Journal: Nature Date: 2000-04-27 Impact factor: 49.962
Authors: W W I Kalk; A Vissink; B Stegenga; H Bootsma; A V Nieuw Amerongen; C G M Kallenberg Journal: Ann Rheum Dis Date: 2002-02 Impact factor: 19.103
Authors: Joanna Groom; Susan L Kalled; Anne H Cutler; Carl Olson; Stephen A Woodcock; Pascal Schneider; Jurg Tschopp; Teresa G Cachero; Marcel Batten; Julie Wheway; Davide Mauri; Dana Cavill; Tom P Gordon; Charles R Mackay; Fabienne Mackay Journal: J Clin Invest Date: 2002-01 Impact factor: 14.808
Authors: S C van Blokland; C G van Helden-Meeuwsen; A F Wierenga-Wolf; H A Drexhage; H Hooijkaas; J P van de Merwe; M A Versnel Journal: Lab Invest Date: 2000-04 Impact factor: 5.662
Authors: W W Kalk; A Vissink; F K Spijkervet; H Bootsma; C G Kallenberg; A V Nieuw Amerongen Journal: Ann Rheum Dis Date: 2001-12 Impact factor: 19.103
Authors: F Mackay; S A Woodcock; P Lawton; C Ambrose; M Baetscher; P Schneider; J Tschopp; J L Browning Journal: J Exp Med Date: 1999-12-06 Impact factor: 14.307
Authors: N Roescher; J L Vosters; G Alsaleh; P Dreyfus; S Jacques; G Chiocchia; J Sibilia; P P Tak; J A Chiorini; X Mariette; Jacques-Eric Gottenberg Journal: Mol Ther Date: 2013-12-05 Impact factor: 11.454
Authors: Tamer I Mahmoud; Jingya Wang; Jodi L Karnell; Qiming Wang; Shu Wang; Brian Naiman; Phillip Gross; Philip Z Brohawn; Chris Morehouse; Jordan Aoyama; Clive Wasserfall; Laura Carter; Mark A Atkinson; David V Serreze; Helen Braley-Mullen; Tomas Mustelin; Roland Kolbeck; Ronald Herbst; Rachel Ettinger Journal: Sci Transl Med Date: 2016-10-19 Impact factor: 17.956
Authors: Hongen Yin; Javier Cabrera-Perez; Zhenan Lai; Drew Michael; Melodie Weller; William D Swaim; Xibao Liu; Marcelo A Catalán; Eduardo M Rocha; Nevien Ismail; Sandra Afione; Noreen A Rana; Giovanni Di Pasquale; Ilias Alevizos; Indu Ambudkar; Gabor G Illei; John A Chiorini Journal: Arthritis Rheum Date: 2013-12
Authors: Yaping Ju; Srikanth Reddy Janga; Wannita Klinngam; J Andrew MacKay; Dillon Hawley; Driss Zoukhri; Maria C Edman; Sarah F Hamm-Alvarez Journal: Exp Eye Res Date: 2018-09-08 Impact factor: 3.467
Authors: Saeed Khalili; Younan Liu; Mara Kornete; Nienke Roescher; Shohta Kodama; Alan Peterson; Ciriaco A Piccirillo; Simon D Tran Journal: PLoS One Date: 2012-06-07 Impact factor: 3.240
Authors: Nienke Roescher; Jelle L Vosters; Zhenan Lai; Toshimitsu Uede; Paul P Tak; John A Chiorini Journal: PLoS One Date: 2012-12-26 Impact factor: 3.240